If you manage diabetes, you know that a reliable continuous glucose monitor can make a real difference in your daily routine. The Eversense 365 has already stood out as the only implantable CGM that lasts a full year under your skin, cutting down on the hassle of frequent sensor changes. This new software aims to improve how you interact with your data and manage your glucose levels more effectively. You can expect the updated app to arrive in the U.S. in the second half of 2026, with a European launch following early next year.
Redesigned Interface and Seamless Health Ecosystem Integration
Beyond the timeline, the most noticeable change will be how the Eversense 365 app looks and feels on your phone. The partnership brings a completely revamped interface with improved visual components and workflows for all features. That means clearer graphs, simpler navigation, and fewer taps to get to the information you need. Instead of digging through menus, you will find your glucose trends, alerts, and settings presented in a more intuitive layout. This redesign focuses on making the CGM app user interface less cluttered and more actionable, so you can spend less time figuring out the app and more time managing your health.
The update also tackles a common frustration: keeping all your health data in one place. The new app will facilitate seamless integration with Apple Health and Google Health Connect. This health data sync means your glucose readings can automatically flow into your preferred health dashboard alongside steps, sleep, and other metrics. For diabetes app integration, this is a practical step toward a unified view of your well-being. You will no longer need to manually export or enter data — the Eversense 365 app handles the connection in the background. Whether you use Apple Health or Google Health Connect, your glucose information becomes part of your broader health picture, making it easier to spot patterns and share comprehensive data with your care team. This seamless ecosystem integration transforms the app from a standalone tool into a connected hub for daily diabetes management.
AI-Powered Diabetes Management and Automated Insulin Delivery Support
That connected hub gets even smarter when you look under the hood. The Eversense 365 app integrates Welldoc’s AI-driven platform, which means it can do much more than just display your sensor readings. One of the standout features is a bolus calculator that takes your real-time CGM data into account. Instead of manually crunching numbers or guessing your dose, the app can suggest an insulin bolus based on your current glucose level, trend arrow, and any carbs you log. This kind of AI diabetes management helps reduce the guesswork and can lead to more consistent time-in-range.
Beyond bolus support, the platform also handles medication management and metabolic tracking. You get a logbook that automatically records your glucose data alongside insulin doses, meals, and activity. The app can even offer educational resources tailored to your patterns, helping you understand what drives your highs and lows. All of this runs on Welldoc’s proven AI engine, which learns from your data over time to provide increasingly personalized recommendations.
Another critical piece of the puzzle is the continued compatibility with the Sequel Med Tech twiist automated insulin delivery system. If you use the twiist pump, the Eversense 365 app will still work hand-in-hand with it to create a closed-loop setup. The sensor data flows directly into the pump’s algorithm, enabling automatic insulin adjustments without constant manual input. This Sequel twiist integration means you get the benefits of both a long-lasting implantable sensor and a smart pump that responds to your body in real time. The app serves as the control center, letting you monitor the system, adjust settings, and review performance—all from your phone.
Enhanced Hardware Interaction and User Experience
From that control center in your pocket, the Eversense 365 app connects directly with the hardware on your body. The system relies on three key physical components: a small implant placed under your skin, a removable CGM transmitter that sits on top, and a daily-changeable adhesive patch for CGM that holds the transmitter in place. The implant continuously measures your glucose levels and sends that data to the transmitter. You attach the transmitter to your skin using a silicone-based adhesive, and here’s the practical benefit: you can swap that adhesive patch every day with almost no skin reactions. This skin-friendly sensor design means less irritation and more comfort over time.
The transmitter then sends your glucose readings to the Eversense 365 app, where you can evaluate your levels and take action. The app’s latest updates focus on making the whole process smoother. Enhanced sensor and transmitter integration covers pairing, activation, and communication status. You get clearer synchronization between the transmitter and the app, along with improved data displays and smarter alerts. That means fewer hiccups when you first set up the system or when you swap in a new transmitter. Everything feels more reliable and less fiddly, so you can trust the numbers on your screen.
What the Upgrade Means for Current Eversense 365 Users
If you already wear the Eversense 365 — the implantable CGM that rests under your skin for a full year — you’re probably wondering how this new app upgrade affects your daily routine. The good news is that the enhancements focus squarely on sensor and transmitter integration: pairing, activation, communication status, synchronization, data displays, and alerts. That means the updated Eversense 365 app is designed to work with the hardware you already have. You won’t need to swap out your sensor or buy a new transmitter just to get the smoother experience.
Tim Goodnow, CEO of Senseonics, noted that the partnership with Welldoc is a natural fit and that the company is committed to improving the CGM experience. This isn’t a one-off tweak — it signals a longer-term investment in making the app more reliable and easier to use. For existing users, that commitment should translate into fewer frustrating moments when you’re trying to sync your phone with your sensor or when you need a clear alert at a critical time.
Still, some details remain up in the air. Pricing and subscription models for the upgraded app haven’t been announced yet, and it’s unclear whether a CGM firmware update will be required to take full advantage of the new features. If you’re already using the system, keep an eye on official communications for specifics on how and when the update will roll out. The core promise, though, is strong: better diabetes app compatibility and a more seamless connection between your phone and your implant. For current users, that’s a welcome step forward.
Frequently Asked Questions
How will the Eversense 365 app integrate with Apple Health and Google Health Connect?
The updated app will sync your glucose data directly to Apple Health and Google Health Connect. This allows you to view your readings alongside other health metrics like activity and sleep in one place. You can then share this combined data with your healthcare provider for a more complete picture of your daily management.
Will the next-generation Eversense 365 app be backward-compatible with the current implant and transmitter?
Yes, the new app is designed to work with your existing Eversense 365 implant and transmitter. You will not need to replace your current hardware to use the updated software. This ensures a smooth transition when the app becomes available.
Will the new Eversense 365 app require a subscription or additional fee?
The app itself will be available as a free update for current Eversense 365 users. There is no separate subscription fee to access the core app features. Any potential costs would be tied to your existing sensor and transmitter supplies, not the software.
